Is Clearside Biomedical Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: CLSD) stock is to Buy CLSD stock.
Out of 3 analysts, 0 (0%) are recommending CLSD as a Strong Buy, 3 (100%) are recommending CLSD as a Buy, 0 (0%) are recommending CLSD as a Hold, 0 (0%) are recommending CLSD as a Sell, and 0 (0%) are recommending CLSD as a Strong Sell.
What is CLSD's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: CLSD) forecast ROE is N/A, which is considered weak.
What is CLSD's Price Target?
According to 3 Wall Street analysts that have issued a 1 year CLSD price target, the average CLSD price target is $5.33, with the highest CLSD stock price forecast at $6.00 and the lowest CLSD stock price forecast at $4.00.
On average, Wall Street analysts predict that Clearside Biomedical's share price could reach $5.33 by Jun 1, 2024. The average Clearside Biomedical stock price prediction forecasts a potential upside of 319.92% from the current CLSD share price of $1.27.
What is CLSD's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: CLSD) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.1%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.